139 related articles for article (PubMed ID: 7603783)
1. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome.
Mäkelä-Bengs P; Suomalainen A; Majander A; Rapola J; Kalimo H; Nuutila A; Pihko H
Pediatr Res; 1995 May; 37(5):634-9. PubMed ID: 7603783
[TBL] [Abstract][Full Text] [Related]
2. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome.
Santorelli FM; Shanske S; Macaya A; DeVivo DC; DiMauro S
Ann Neurol; 1993 Dec; 34(6):827-34. PubMed ID: 8250532
[TBL] [Abstract][Full Text] [Related]
3. NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein.
López-Gallardo E; Solano A; Herrero-Martín MD; Martínez-Romero I; Castaño-Pérez MD; Andreu AL; Herrera A; López-Pérez MJ; Ruiz-Pesini E; Montoya J
J Med Genet; 2009 Jan; 46(1):64-7. PubMed ID: 19124644
[TBL] [Abstract][Full Text] [Related]
4. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants.
Mattiazzi M; Vijayvergiya C; Gajewski CD; DeVivo DC; Lenaz G; Wiedmann M; Manfredi G
Hum Mol Genet; 2004 Apr; 13(8):869-79. PubMed ID: 14998933
[TBL] [Abstract][Full Text] [Related]
5. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study.
Rojo A; Campos Y; Sánchez JM; Bonaventura I; Aguilar M; García A; González L; Rey MJ; Arenas J; Olivé M; Ferrer I
Acta Neuropathol; 2006 Jun; 111(6):610-6. PubMed ID: 16525806
[TBL] [Abstract][Full Text] [Related]
6. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load.
Enns GM; Bai RK; Beck AE; Wong LJ
Mol Genet Metab; 2006 Aug; 88(4):364-71. PubMed ID: 16546428
[TBL] [Abstract][Full Text] [Related]
7. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
[TBL] [Abstract][Full Text] [Related]
8. High mitochondrial DNA T8993G mutation (<90%) without typical features of Leigh's and NARP syndromes.
Tsao CY; Mendell JR; Bartholomew D
J Child Neurol; 2001 Jul; 16(7):533-5. PubMed ID: 11453454
[TBL] [Abstract][Full Text] [Related]
9. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
Holt IJ; Harding AE; Petty RK; Morgan-Hughes JA
Am J Hum Genet; 1990 Mar; 46(3):428-33. PubMed ID: 2137962
[TBL] [Abstract][Full Text] [Related]
10. Stability of the m.8993T->G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome.
Steffann J; Gigarel N; Corcos J; Bonnière M; Encha-Razavi F; Sinico M; Prevot S; Dumez Y; Yamgnane A; Frydman R; Munnich A; Bonnefont JP
J Med Genet; 2007 Oct; 44(10):664-9. PubMed ID: 17545557
[TBL] [Abstract][Full Text] [Related]
11. [Leigh syndrome resulting from a de novo mitochondrial DNA mutation (T8993G)].
Playán A; Solano-Palacios A; González de la Rosa JB; Merino-Arribas JM; Andreu AL; López-Pérez M; Montoya J
Rev Neurol; 2002 Jun 16-30; 34(12):1124-6. PubMed ID: 12134275
[TBL] [Abstract][Full Text] [Related]
12. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.
Parfait B; de Lonlay P; von Kleist-Retzow JC; Cormier-Daire V; Chrétien D; Rötig A; Rabier D; Saudubray JM; Rustin P; Munnich A
Eur J Pediatr; 1999 Jan; 158(1):55-8. PubMed ID: 9950309
[TBL] [Abstract][Full Text] [Related]
13. Adult-onset ataxia and polyneuropathy caused by mitochondrial 8993T-->C mutation.
Rantamäki MT; Soini HK; Finnilä SM; Majamaa K; Udd B
Ann Neurol; 2005 Aug; 58(2):337-40. PubMed ID: 16049925
[TBL] [Abstract][Full Text] [Related]
14. Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G).
Pastores GM; Santorelli FM; Shanske S; Gelb BD; Fyfe B; Wolfe D; Willner JP
Am J Med Genet; 1994 Apr; 50(3):265-71. PubMed ID: 8042671
[TBL] [Abstract][Full Text] [Related]
15. [Diseases caused by mutations in mitochondrial DNA].
Wojewoda M; Zabłocki K; Szczepanowska J
Postepy Biochem; 2011; 57(2):222-9. PubMed ID: 21913424
[TBL] [Abstract][Full Text] [Related]
16. Defective mitochondrial ATPase due to rare mtDNA m.8969G>A mutation-causing lactic acidosis, intellectual disability, and poor growth.
Isohanni P; Carroll CJ; Jackson CB; Pohjanpelto M; Lönnqvist T; Suomalainen A
Neurogenetics; 2018 Jan; 19(1):49-53. PubMed ID: 29350304
[TBL] [Abstract][Full Text] [Related]
17. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome.
de Vries DD; van Engelen BG; Gabreëls FJ; Ruitenbeek W; van Oost BA
Ann Neurol; 1993 Sep; 34(3):410-2. PubMed ID: 8395787
[TBL] [Abstract][Full Text] [Related]
18. Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene.
Nijtmans LG; Henderson NS; Attardi G; Holt IJ
J Biol Chem; 2001 Mar; 276(9):6755-62. PubMed ID: 11076946
[TBL] [Abstract][Full Text] [Related]
19. [Various manifestations of the A8344G mtDNA heteroplasmic mutation in 4 families with the MERRF syndrome].
Stratilová L; Zeman J; Houst'ková H; Hansíková H; Konrádová V; Hůlková H; Elleder M; Růzicka E; Tyl D; Hrubá E; Houstĕk J
Cas Lek Cesk; 1999 Jun; 138(13):401-5. PubMed ID: 10566210
[TBL] [Abstract][Full Text] [Related]
20. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families].
Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J
Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]